The Abraaj Group backs Clinique Taoufik

The Abraaj Group has acquired a majority stake in Polyclinique Taoufik. Based in Tunis, Clinique Taoufik is a private healthcare institution.

PRESS RELEASE

The Abraaj Group (‘Abraaj’ or ‘The Group’), a leading investor operating in global growth markets, today announced the acquisition of a majority stake, through its Funds, in Polyclinique Taoufik S.A. (‘Clinique Taoufik’ or ‘the company’), a leading private hospital in Tunisia.

Based in Tunis, Clinique Taoufik was one of the first private healthcare institutions established as part of efforts to modernize Tunisia’s healthcare system. The hospital currently treats 75,000 in- and out-patients per year, offering services such as general surgery, heart surgery, neurosurgery and obstetrics. The company also has an emergency service, a radiology center and laboratory dedicated to patients of the hospital.

Clinique Taoufik is a leading private hospital in Tunisia in terms of brand recognition and revenue. With 164 beds, the hospital is the second largest in terms of bed capacity. With Abraaj’s financial and operational support, it aims to consolidate this position by further increasing patient capacity and adding new services, upgrading and renovating the hospital, and investing in human resources and training.

To implement its growth strategy for Clinique Taoufik, Abraaj will draw on its extensive experience in the healthcare sector, gained from investing in businesses across the Middle East, North Africa and Turkey, including Acibadem, a leading healthcare group in Turkey, Unimed in Tunisia and Integrated Diagnostics Holdings in Egypt.

Ahmed Badreldin, Partner and Head of Middle East and North Africa at The Abraaj Group, said: “Our investment in Clinique Taoufik marks our sixth investment in Tunisia and enables us to execute our wider strategy of acquiring robust and innovative businesses in critical sectors such as healthcare. We are backing a company with strong growth potential as the North African population is expected to reach 190 million by 2020, with life expectancy also on the rise, contributing to increasing demand for quality healthcare services.”

Adel Goucha, Director at The Abraaj Group, added: “Clinique Taoufik is well-positioned as one of the leading private hospitals in the Tunisian healthcare sector, an industry which made up almost seven per cent of GDP last year. We look forward to working closely with the clinic’s management to implement its expansion plans and capitalize on the growing market opportunities this sector presents.”

Leila Kefi, Chief Executive Officer of Clinique Taoufik, said: “We are excited to partner with the Abraaj team, who will help to accelerate Clinique Taoufik’s growth, and further build on our leading position in the healthcare delivery sector. We are confident that Abraaj’s strong experience in the healthcare industry and wider region make them the ideal investor for us.”

Abraaj has a strong track record of investing in Tunisian companies, with its portfolio including Moulin d’Or, a highly successful baked goods company; Unimed, a leading player in sterile form pharmaceutical products; and Plastic Electromechanic Company (PEC), which specializes in plastic injection, the assembly of electrical equipment and harnesses, and medical products.

Get your FREE trial or subscribe now to Buyouts to find new deal opportunities, super-charge your fundraising efforts and track top managers.

Sign up to our Newsletter

Receive updates from our PE HUB Wire and Top Stories of the Week newsletters:

First Name:

Last Name:

Email Address:

US Edition (daily)

Canada Edition (weekly)

We will not send you spam, and we don't share your email address with 3rd parties.

You are now subscribed to the PEHub Wire and Top Stories of the Week newsletters.

Buyouts Insider/Argosy Group LLC produces several free newsletters that are sent directly to the email you provide at registration (namely, PE Hub Wire, PE Hub Canada Wire, PE Hub Wire Top Story of the Week, Buyouts Daily, and VCJ Alert). To enable us to keep providing these services free of charge, we reserve the right to contact you with special invitations to sample or purchase private equity-related products.

By submitting this free subscription request for any of these products, you are also consenting to this communication. Should you ever wish to unsubscribe from a particular communication you may activate the unsubscribe mechanism at the bottom of the email. This will discontinue both the special invitations mentioned previously, as well as your subscription to the weekly newsletter. The information you provide will be safeguarded by Argosy Group LLC/Buyouts Insider. The company’s subsidiaries may use it to keep you informed of relevant products and services. We occasionally allow reputable companies outside of the company to mail details of products which may be of interest to you. As an international group, we may transfer your data on a global basis for the purposes indicated above.

WE WILL NEVER SHARE YOUR EMAIL OR CONTACT DETAILS WITH ANY OUTSIDE COMPANY HOWEVER.

Should you have any questions please do not hesitate to contact us: [email protected].